McKesson Corporation Total Liabilities
McKesson Corporation total liabilities. Based on the latest financial reports, McKesson Corporation (MCK) has total liabilities worth $92.19 Billion USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check how resilient are McKesson Corporation's assets to evaluate the company's liquid asset resilience ratio.
Total Liabilities of McKesson Corporation (1995–2026)
Total liabilities of McKesson Corporation from 1995 to 2026. This chart illustrates how McKesson Corporation's total liabilities have evolved over time, based on quarterly financial data. Explore MCK long-term investments to assets to see how much of total assets are deployed in long-term investments.
McKesson Corporation Competitors by Total Liabilities
The table below lists competitors of McKesson Corporation ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Corning Incorporated
NYSE:GLW
|
USA | $18.90 Billion |
|
CME Group Inc
NASDAQ:CME
|
USA | $175.38 Billion |
|
Grupo México S.A.B. de C.V
MX:GMEXICOB
|
Mexico | MX$17.34 Billion |
|
UBS Group AG
SW:UBSG
|
Switzerland | CHF1.53 Trillion |
|
GSK PLC SP. ADR/2 NEW
F:GS70
|
Germany | €44.56 Billion |
|
Air Liquide SA
PA:AI
|
France | €24.97 Billion |
|
CVS Health Corp
NYSE:CVS
|
USA | $185.68 Billion |
|
Snowflake Inc.
NYSE:SNOW
|
USA | $6.61 Billion |
Liability Composition Analysis (1995–2026)
This chart breaks down McKesson Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see McKesson Corporation asset portfolio.
Liquidity & Leverage Metrics
McKesson Corporation Total Liabilities Ratios Explained
McKesson Corporation total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.89 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -21.74 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.04 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how McKesson Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for McKesson Corporation (1995–2026)
The table below shows the annual total liabilities of McKesson Corporation from 1995 to 2026.
| Year | Total Liabilities | Change |
|---|---|---|
| 2026-03-31 | $83.16 Billion | +8.23% |
| 2025-03-31 | $76.83 Billion | +11.29% |
| 2024-03-31 | $69.04 Billion | +8.20% |
| 2023-03-31 | $63.81 Billion | -1.97% |
| 2022-03-31 | $65.09 Billion | +2.39% |
| 2021-03-31 | $63.57 Billion | +16.56% |
| 2020-03-31 | $54.54 Billion | +9.09% |
| 2019-03-31 | $49.99 Billion | +2.31% |
| 2018-03-31 | $48.87 Billion | +1.03% |
| 2017-03-31 | $48.37 Billion | +4.81% |
| 2016-03-31 | $46.15 Billion | +3.94% |
| 2015-03-31 | $44.40 Billion | +7.14% |
| 2014-03-31 | $41.44 Billion | +49.52% |
| 2013-03-31 | $27.72 Billion | +5.54% |
| 2012-03-31 | $26.26 Billion | +10.97% |
| 2011-03-31 | $23.67 Billion | +14.57% |
| 2010-03-31 | $20.66 Billion | +8.30% |
| 2009-03-31 | $19.07 Billion | +3.20% |
| 2008-03-31 | $18.48 Billion | +4.60% |
| 2007-03-31 | $17.67 Billion | +17.27% |
| 2006-03-31 | $15.07 Billion | +11.62% |
| 2005-03-31 | $13.50 Billion | +21.90% |
| 2004-03-31 | $11.07 Billion | +15.02% |
| 2003-03-31 | $9.63 Billion | +4.80% |
| 2002-03-31 | $9.19 Billion | +17.17% |
| 2001-03-31 | $7.84 Billion | +18.60% |
| 2000-03-31 | $6.61 Billion | +10.11% |
| 1999-03-31 | $6.00 Billion | +49.91% |
| 1998-03-31 | $4.01 Billion | +7.75% |
| 1997-03-31 | $3.72 Billion | +56.05% |
| 1996-03-31 | $2.38 Billion | -0.99% |
| 1995-03-31 | $2.41 Billion | -- |
About McKesson Corporation
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; d… Read more